|1.||Ezri, Tiberiu: 2 articles (02/2007 - 08/2004)|
|2.||Sadan, Oscar: 2 articles (02/2007 - 08/2004)|
|3.||Lurie, Samuel: 2 articles (02/2007 - 08/2004)|
|4.||Sarala, N: 1 article (07/2015)|
|5.||Kumar, G Chetan: 1 article (07/2015)|
|6.||Bhuvana, K: 1 article (07/2015)|
|7.||Venkatarathnamma, P N: 1 article (07/2015)|
|8.||Tathineni, Bharath: 1 article (06/2015)|
|9.||Naik, Vikas: 1 article (06/2015)|
|10.||Banday, Tanveer Hassan: 1 article (06/2015)|
08/01/2000 - "Measurements of quantitative alterations of serum pseudocholinesterase levels may be useful in the treatment of patients with chronic spinal pain."
08/01/2000 - "A prospective study of serum pseudocholinesterase levels in patients with chronic spinal pain: a preliminary study."
08/01/2000 - "A correlation demonstrated between visual assessment score and serum pseudocholinesterase in chronic spinal pain patients was not observed in six of nine patients receiving disability payments for more than a year. "
08/01/2000 - "To determine whether there is a statistically significant correlation between variations of serum pseudocholinesterase and the perception of pain in patients with chronic spinal pain. "
08/01/2000 - "The mean preoperative serum pseudocholinesterase level of chronic spinal pain patients (1313; SE = 26), which was significantly higher than the mean levels of the normal control volunteers (941; SE = 24; P<0.001) and that of surgical control subjects (1018; SE = 63; P <0.01), decreased significantly with anesthesia (P<0.005). "
12/01/2000 - "The prolonged paralysis supposedly caused by intraoperative use of succinylcholine was recognized and confirmed by laboratory examination which showed low pseudocholinesterase activity. "
05/01/1972 - "Antagonism of succinylcholine paralysis in a patient with atypical pseudocholinesterase."
09/01/2002 - "A 7-h period of apnea and paralysis after administration of succinylcholine was attributed to the decreased rate of succinylcholine metabolism resulting from inhibition of pseudocholinesterase by the insecticide. "
04/01/1996 - "Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro."
02/01/2002 - "Patients with pseudocholinesterase (BChE) variants may exhibit markedly prolonged paralysis after the administration of succinylcholine or mivacurium. "
07/01/1981 - "Following an introduction on the question of pseudocholinesterase (CHE) in cirrhosis of the liver and acute and chronic hepatopathy, a personal study of 35 chronic cases at various stages of the disease is reported. "
01/01/1981 - "This paper was designed to study experimentally in rats hepatic and serum pseudocholinesterase, (CHE), and its isoenzyme activity, and also to analyze its behavior in acute hepatitis, cirrhosis and primary and secondary hepatic tumours. "
01/01/1986 - "The concentration of bile acids in serum more closely correlated with mortality in cirrhosis than the commonly used clinical and laboratory parameters such as the Number Connection Test, ascites, albumin, pseudocholinesterase, bilirubin, prothrombin time and nutritional state. "
|4.||Uterine Cervical Neoplasms (Cancer of the Cervix)
12/01/2000 - "The objectives of this study were to investigate: 1) the activity of pseudocholinesterase (PChE) in patients with uterine cervical cancer in different stages (uterine cervical carcinoma in stages II b and III and recurrent cervical carcinoma in stages III and IV a,b) and to compare it to the enzyme activity in patients with benign tumour of the uterus, and 2) the effects of radiotherapy on enzyme activity in those patients with uterine cervical carcinoma for which the chosen treatment was radical radiotherapy. "
01/01/2008 - "In the present study, we estimated serum pseudocholinesterase (PCHE), serum aspartate transaminase (AST), and serum alanine transaminase (ALT) in 92 patients with head and neck cancer and 71 patients with cancer of the uterine cervix; all of them were patients attending our department for radiation therapy. "
06/01/2015 - "Diagnosis of OP poisoning was based on clinical history of exposure to OP compound and low serum pseudocholinesterase levels. "
12/01/2012 - "Mean pseudocholinesterase levels in our patients with mad honey poisoning were 7139.30 ± 2316.41 U/L (min-max: 1785-12,835). "
12/01/2012 - "Pseudocholinesterase levels are not decreased in grayanotoxin (mad honey) poisoning in most patients."
10/01/2010 - "Out of 26 cases about 60% of poisoning cases were monitored for pseudocholinesterase level. "
10/01/2005 - "Pseudocholinesterase activity in organophosphate poisoning after storage of unseparated blood samples at room temperature for 3 weeks."
|1.||mivacurium (mivacurium chloride)
|2.||Neostigmine (Neostigmine Bromide)
|5.||Alanine Transaminase (SGPT)
|7.||Aspartate Aminotransferases (Aspartate Transaminase)
|8.||Hepatitis B Surface Antigens (HBsAg)
|10.||Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)
|3.||Drug Therapy (Chemotherapy)